The Randomized Response Technique (Warner, Journal of the American Statistical Association, 60, 63-69, 1965) has been developed to control for socially desirable responses in surveys on sensitive attributes. The Crosswise Model (CWM; Yu et al., Metrika, 67, 251-263, 2008) and its extension, the Extended Crosswise Model (ECWM; Heck et al., Behavior Research Methods, 50, 1895-1905, 2018), are advancements of the Randomized Response Technique that have provided promising results in terms of improved validity of the obtained prevalence estimates compared to estimates based on conventional direct questions. However, recent studies have raised the question as to whether these promising results might have been primarily driven by a methodological artifact in terms of random responses rather than a successful control of socially desirable responding. The current study was designed to disentangle the influence of successful control of socially desirable responding and random answer behavior on the validity of (E)CWM estimates. To this end, we orthogonally manipulated the direction of social desirability (undesirable vs. desirable) and the prevalence (high vs. low) of sensitive attributes. Our results generally support the notion that the ECWM successfully controls social desirability bias and is inconsistent with the alternative account that ECWM estimates are distorted by a substantial influence of random responding. The results do not rule out a small proportion of random answers, especially when socially undesirable attributes with high prevalence are studied, or when high randomization probabilities are applied. Our results however do rule out that random responding is a major factor that can account for the findings attesting to the improved validity of (E)CWM as compared with DQ estimates.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023046 | PMC |
http://dx.doi.org/10.3758/s13428-022-01819-2 | DOI Listing |
Nicotine Tob Res
January 2025
Institute for Nicotine and Tobacco Studies, Rutgers Health, New Brunswick, NJ, USA.
Introduction: Accurate measurement is critical for understanding the population health impact of nicotine pouches, yet precise, standardized measures of nicotine pouch use are lacking, possibly driving disparate prevalence estimates across studies. We implemented a split sample survey experiment to assess the impact of including a product image when asking about nicotine pouches.
Methods: We randomized an online sample of US adults ages 18-45 (N=2,130) recruited through the February 2023 wave of the Rutgers Omnibus Study to view either a text-only or text-plus-image description of oral nicotine pouches before being asked about awareness of the products.
J Infect Dev Ctries
December 2024
Students' Research Committee, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Introduction: Inflammation plays a role in coronavirus disease 2019 (COVID-19) pathophysiology and anti-inflammatory drugs may help reduce the disease severity. Levamisole is an anthelmintic drug with immunomodulatory and possible antiviral effects. This study aimed to evaluate the role of levamisole in the treatment of patients with COVID-19.
View Article and Find Full Text PDFJ Assist Reprod Genet
January 2025
Evidence Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China.
Poor ovarian response (POR) significantly impacts the success of assisted reproductive technology (ART), and growth hormone (GH) has been proposed as an adjuvant treatment to improve outcomes in POR patients undergoing in vitro fertilization (IVF). A systematic review and meta-analysis were conducted to evaluate the effectiveness of GH in enhancing pregnancy outcomes, registering a protocol on PROSPERO and searching multiple databases up to September 2023. Twelve systematic reviews/meta-analysis and 20 randomized controlled trials (RCTs) involving 1984 patients were included.
View Article and Find Full Text PDFAnn Med
December 2025
Heart Centre, Turku University Hospital, Turku, Finland.
Background: Several randomized controlled trials (RCTs) have investigated the benefits of atrial fibrillation (AF) screening. However, since none have shown a significant reduction in stroke rates, the impact of screening on clinical outcomes remains uncertain.
Materials And Methods: We conducted a systematic review and meta-analysis of RCTs reporting clinical outcomes of systematic AF screening in participants without known AF.
Br J Dermatol
January 2025
Department of Dermatology, Yale University, New Haven, Connecticut, USA.
Background: Overexpression of interleukin (IL)-17A and IL-17F significantly influences psoriasis pathology. Until recently, biologics targeting IL-17A alone, like secukinumab, were used to treat psoriasis. Bimekizumab is a monoclonal IgG1 antibody that targets both IL-17A and IL-17F.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!